Advanced therapies inspired for you

Defymed is a company that develops and markets implantable bio-artificial medical devices for diverse therapeutic applications.

Watch the video

Our basic aim is to develop breakthrough innovations that enhance drug delivery systems leading to improvements in the quality of life of patients.

Séverine Sigrist, Defymed CEO Who are we ?

Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life

Patients

500

million diabetics worldwide forecasted for 2035

Expenses

$ 750

billion per year spent on diabetes-related expenses

Treatments

more than 10

million diabetics receiving insulin therapy have poorly regulated blood glucose levels

A bio-artificial pancreas intended to be filled with insulin-secreting cells in order to regulate blood glucose levels in a more physiological way

More about MailPan®

An insulin delivery device that makes injections of insulin more efficient

More about ExOlin®
  • Team

    Reinventing together health innovation

    Team
  • Top notch network

    International partnerships focused on open innovation

    Top notch network
  • Breakthrough technologies

    Your health challenges our innovation

    Technologies
  • Service Provision

    Full chain R&D facilities, combining both in vitro and in vivo assays, using well established experimental models

    Service Provision
  • Quality

    ISO-13485 & 9001 to guarantee the safety of our medical devices and optimize our corporate performance

    Certificate